Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

10090	Companies
206386	Keywords
136540	Articles
109380	Press releases

Home
Companies
Heidelberg Pharma AG

PRESS RELEASE

published on 01/13/2025 at 08:17, 1 year 2 months ago

Heidelberg Pharma Progresses into Cohort 7 in a Phase I/IIa Study with BCMA ATAC Candidate HDP-101 Targeting Multiple Myeloma
Heidelberg Pharma advances into Cohort 7 with BCMA ATAC candidate HDP-101 targeting multiple myeloma, showing promising results and complete remission in Phase I/IIa study

Heidelberg Pharma Multiple Myeloma Phase I/IIa Study Complete Remission BCMA ATAC
BRIEF

published on 11/06/2024 at 10:07, 1 year 4 months ago

Heidelberg Pharma Reveals Promising Data on HDP-101 at ASH 2024

Clinical Data Heidelberg Pharma HDP-101 ADC Technology Multiple Myeloma
BRIEF

published on 11/06/2024 at 10:07, 1 year 4 months ago

Heidelberg Pharma dévoile des données prometteuses sur le HDP-101 à l'ASH 2024

Heidelberg Pharma HDP-101 Myélome Multiple Données Cliniques Technologie ADC
PRESS RELEASE

published on 11/06/2024 at 10:02, 1 year 4 months ago

Heidelberg Pharma: Promising New Clinical Data on Lead ADC-Candidate HDP-101 to be Presented at ASH Annual Meeting 2024
Heidelberg Pharma AG to present promising new clinical data on lead ADC-candidate HDP-101 at ASH Annual Meeting 2024, showcasing potential for multiple myeloma treatment

Clinical Data HDP-101 Heidelberg Pharma AG ADC ASH Annual Meeting
BRIEF

published on 10/24/2024 at 11:08, 1 year 5 months ago

Heidelberg Pharma to Showcase Its ADC Innovations in November 2024

Cancer Therapy Heidelberg Pharma HDP-101 ADCs HDP-201
BRIEF

published on 10/24/2024 at 11:08, 1 year 5 months ago

Heidelberg Pharma présentera ses innovations ADC en novembre 2024

Heidelberg Pharma HDP-101 Thérapie Contre Le Cancer ADC HDP-201
PRESS RELEASE

published on 10/24/2024 at 11:03, 1 year 5 months ago

Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024
Heidelberg Pharma to present ADC candidates at scientific and financial conferences in November 2024. Updates on Amanitin-based HDP-101 and Exatecan-based HDP-201. Key targets and conference details

Heidelberg Pharma Scientific Conferences ADC Candidates Amanitin Exatecan
BRIEF

published on 10/10/2024 at 07:11, 1 year 5 months ago

Heidelberg Pharma AG's Interim Report for First Nine Months of 2024

Financial Report Heidelberg Pharma HDP-101 Trial Clinical Outcomes Royalty Sale
BRIEF

published on 10/10/2024 at 07:11, 1 year 5 months ago

Rapport intermédiaire de Heidelberg Pharma AG pour les neuf premiers mois de 2024

Rapport Financier Heidelberg Pharma Résultats Cliniques Essai Du HDP-101 Vente De Redevances
PRESS RELEASE

published on 10/10/2024 at 07:06, 1 year 5 months ago

Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2024
Heidelberg Pharma AG provides insights on its operational progress and financial figures for the first nine months of fiscal year 2024. Development activities, new clinical data, R&D webinars, and guidance updates are highlighted

Financial Figures Clinical Data Heidelberg Pharma AG R&D Webinars Guidance Updates

Accesswire

Published on 03/25/2026 at 13:30, 13 minutes ago

Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Published on 03/25/2026 at 13:30, 13 minutes ago

Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification
Published on 03/25/2026 at 13:30, 13 minutes ago

Strategic Metals Closes Project Sale
Published on 03/25/2026 at 13:25, 18 minutes ago

Predictiv AI Expands Active Deployment of CloudRep.ai Across Healthcare, Retail, Real Estate, Travel and Global Markets
Published on 03/25/2026 at 13:20, 23 minutes ago

Lobe Sciences Ltd. Reports Improved Financial Position and Strategic Update

View all ACCESSWIRE

EQS Group

Published on 03/25/2026 at 13:35, 7 minutes ago

Bitmine Immersion Technologies (BMNR) Announces Launch of MAVAN (Made In America VAlidator Network), the Company's Proprietary Staking Solution
Published on 03/25/2026 at 13:15, 27 minutes ago

Kontron AG resolves on a new Share Buyback Program I 2026 for own shares
Published on 03/25/2026 at 13:10, 32 minutes ago

NAKIKI SE Publishes 2025 Half-Year Financial Statements
Published on 03/25/2026 at 13:10, 32 minutes ago

Geneva becomes world's capital of AI in July for ITU's AI for Good Global Summit
Published on 03/25/2026 at 12:55, 47 minutes ago

EQS-Adhoc: Kontron AG: Kontron AG resolves on a new Share Buyback Program I 2026 for own shares

Les Echos

Published on 03/25/2026 at 08:45, 4 hours 58 minutes ago

Air Liquide inaugurates its first Advanced Materials manufacturing plant in Taiwan, strengthening the next-gen semiconductor supply chain
Published on 03/25/2026 at 08:45, 4 hours 58 minutes ago

Air Liquide inaugure sa première usine de production de Matériaux Avancés à Taïwan, renforçant ainsi la chaîne d'approvisionnement en semi-conducteurs de nouvelle génération
Published on 03/25/2026 at 07:00, 6 hours 43 minutes ago

TINC invests in large-scale battery storage to strengthen the flexibility of the Belgian electricity network (B)
Published on 03/25/2026 at 07:00, 6 hours 43 minutes ago

TINC investeert in grootschalige batterijopslag ter versterking van de flexibiliteit van het Belgische stroomnetwerk (B)
Published on 03/25/2026 at 07:00, 6 hours 43 minutes ago

TINC invests in large-scale battery storage to strengthen the flexibility of the Belgian electricity network (B)

View all LES ECHOS COMFI WIRE